BioCardia, Inc. (BCDA) stock

BCDANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026Score 5/30

$0.92−0.01 (-0.91%)

Close on Nov 11, 2026Market cap $13.95MP/E –Yield –

BioCardia EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

BioCardia's EV/EBITDA was 876.8× on Jan 29, 2016.

Period	Period end	Value	Change (pts)
2016	Jan 29, 2016	876.8×	+0.0
2015	Dec 31, 2015	876.8×	+352.0
2011	Apr 29, 2011	524.8×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is BCDA.

Revenue growth-100.0% · median -50.0%

Advertisement
300 × 250

See a number that looks wrong?